Leading Istanbul hospital will host news conference to educate public about a safe, well-tolerated and innovative treatment
Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services to the global health science market, today celebrated the first anniversary of the market introduction of TheraSphere[1], an innovative radioembolic liver cancer therapy, in the Republic of Turkey. The first treatment was administered in Ankara in December 2010. Since then, more than 80 patients have undergone the treatment in more than a half-dozen private and public hospitals across the country.
More:VPO Press Release - TheraSphere® Providing Hope to Liver Cancer Patients in Turkey
